NDRA vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

NDRA

48.5
AI Score
VS
CDNA Wins

CDNA

50.7
AI Score

Investment Advisor Scores

NDRA

49score
Recommendation
HOLD

CDNA

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NDRA CDNA Winner
Net Income -8.50M 113.44M CDNA
Operating Income -7.71M 114.42M CDNA
ROE -605.7% 26.7% CDNA
ROA -235.0% 21.3% CDNA
Total Assets 3.62M 532.99M CDNA
Cash 2.28M 373.64M CDNA
Current Ratio 1.61 4.58 CDNA
Free Cash Flow -6.69M 29.26M CDNA

Relative Price Performance (Last 90 Days)

NDRA 1M: -11.4% · 3M: -15.6% CDNA 1M: +63.9% · 3M: +122.6%

Current Technical Phase

NDRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 40

RSI (14): 40.0 · Price: $4.18

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81

RSI (14): 81.5 · Price: $47.85

Fundamentals Snapshot

Metric NDRA CDNA
Market Cap
Forward P/E -1.4 37.2
Trailing P/E 21.0
Revenue (TTM)
Revenue Growth 0.0% 0.5%
Gross Margin 0.7%
Operating Margin 0.0% 0.0%
EPS -8.16 2.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CDNA is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.